Christian Kramme grew up in a big family, the youngest of seven kids raised in California’s Santa Clarita Valley. By the time he moved across the country to do a PhD in George Church’s lab at Harvard, ...
Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body
NEW YORK--(BUSINESS WIRE)--Gameto, a biotechnology company dedicated to advancing treatment option in women's health, announced today the world’s first live human birth using Fertilo, an ovarian ...
Midtown fertility biotech Gameto raised $33 million in a Series B funding round to advance a clinical treatment that aims to make in-vitro fertilization more convenient, the firm said Thursday. The ...
Biotech firm Gameto has raised $44 million from investors to bring a late-stage clinical trial on its fertility treatment over the finish line, the company, which has a lab in Kips Bay and recently ...
AUSTIN, Texas--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies to transform fertility care, today announced that the Reproductive Fertility Center in Corona, ...
Dr. Dina Radenkovic, CEO of Gameto, discusses the use of iPSCs in fertility treatments, the most significant scientific hurdles they've encountered in developing and scaling these therapies ...
As birth rates decline and US IVF access falls further behind, Gameto recruits first Phase 3 patients for cutting-edge biotechnology to reignite reproductive health possibilities Company's $127 ...
A Phase III trial investigating a method of maturing human eggs outside of the body using induced pluripotent stem cells (iPSC) has been given the green light after the US Food and Drug Administration ...
Biotech company Gameto has raised $17 million, bringing its total capital raised to $40 million. Gameto specializes in using cell engineering to develop therapeutics for diseases of the female ...
Gameto is a biotechnology company redefining women’s healthcare through cellular engineering. Focused on solving major challenges in reproductive health, Gameto develops therapies that aim to ...
Gameto, a biotechnology company, has raised $33 million in Series B funding, which it will use to support the clinical development of its in vitro maturation (IVM) product called Fertilo. New York ...
Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied. Scientists have been working on creating in vitro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results